Evidence updates
Emerging weight-loss medications & research.
Clear, evidence-focused education about treatments in clinical trials, newly approved medicines, safety questions, and what remains unknown.
Last Updated: August 2, 2026
Read the evidence in context
Research can be promising without being ready for patients.
Medical weight-loss treatment is evolving quickly. This library separates published research, company announcements, clinical trial status, FDA approval, and real-world availability so readers can understand each without filling in the gaps with hype.
These guides do not recommend a medication or replace care from a qualified clinician. They are designed to make the next healthcare question clearer.
Emerging medication tracker
Where the research stands.
| Medication | Current status | Guide |
|---|---|---|
| Retatrutide | Investigational, Phase 3 results reported | Read guide |
| MariTide | Investigational, Phase 3 program | Coming soon |
| CagriSema | FDA submission reported | Coming soon |
| Oral GLP-1 medications | Approved and investigational options | Coming soon |
Cornerstone guide
Retatrutide for weight loss
Results, side effects, FDA approval status, and the questions patients should ask before believing an online claim.
Read the guide →Coming soon
Next in the library.
MariTide · Oral GLP-1 Medications · CagriSema · Triple Agonists Explained · Medication Comparison Guides · Future FDA Approval Updates
Build a stronger foundation